CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.
Fritzsching B, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Bosch AL, Bernd L, Csóka M, Mechtersheimer G, Ewerbeck V, Kinscherf R, Kunz P.
Fritzsching B, et al. Among authors: sapi z.
Oncoimmunology. 2015 Apr 2;4(3):e990800. doi: 10.4161/2162402X.2014.990800. eCollection 2015 Mar.
Oncoimmunology. 2015.
PMID: 25949908
Free PMC article.